As a Stanford Biodesign Innovation Fellow, Kate Rosenbluth was captivated by the unmet need to treat hand tremors. She discovered that the site of deep brain stimulation was accessible through the peripheral nerves in the wrist, and teamed up with Scott Delp, director of the Stanford Neuromuscular Biomechanics Lab, to found Cala Health, where she is now the chief scientific officer. The company’s wearable neuromodulation therapies merge neuroscience research with cutting-edge technology to deliver individualized peripheral nerve stimulation. Cala Health is also developing new therapies in the areas of neurology, cardiology and psychiatry.
This appearance by Kate Rosenbluth is part of the Entrepreneurial Thought Leaders series. Join us live as we bring founders, investors and industry influencers to center stage and invite them to share what it takes to become a disruptor.